NDC product
Sulfacetamide Sodium and Prednisolone Sodium Phosphate
NDC 24208-317 · Bausch & Lomb Incoporated
Key facts
| Product NDC | 24208-317 |
|---|---|
| Proprietary name | Sulfacetamide Sodium and Prednisolone Sodium Phosphate |
| Nonproprietary name | Sulfacetamide Sodium and Prednisolone Sodium Phosphate |
| Substances | SULFACETAMIDE SODIUM, PREDNISOLONE SODIUM PHOSPHATE |
| Dosage form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Labeler | Bausch & Lomb Incoporated |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA074449 |
| Pharmacologic classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Sulfonamide Antibacterial [EPC], Sulfonamides [CS] |
| Marketing start | Dec 29, 1995 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: